Tenet Healthcare posted GAAP net income available to common shareholders of $826 million in Q2 2026, more than doubled from a year earlier; diluted EPS was $9.84.
GAAP net operating revenues rose 6.8% to $5.63 billion; consolidated adjusted EBITDA climbed 16.3% to $1.3 billion.
Hospital adjusted EBITDA margin widened 2.4 percentage points to 18%; ambulatory adjusted EBITDA increased 8.8% to $542 million.
The board authorized a $2 billion increase to share repurchases; Tenet bought back 5,680,000 shares for $1.04 billion in Q2.
Tenet raised FY 2026 adjusted EBITDA outlook to $4.83 billion-$5.03 billion; adjusted free cash flow is seen at $2.73 billion-$3.03 billion.
THC•
